JP2009517406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009517406A5 JP2009517406A5 JP2008542538A JP2008542538A JP2009517406A5 JP 2009517406 A5 JP2009517406 A5 JP 2009517406A5 JP 2008542538 A JP2008542538 A JP 2008542538A JP 2008542538 A JP2008542538 A JP 2008542538A JP 2009517406 A5 JP2009517406 A5 JP 2009517406A5
- Authority
- JP
- Japan
- Prior art keywords
- assay
- cells
- clones
- serum
- samples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73999505P | 2005-11-28 | 2005-11-28 | |
| PCT/US2006/061285 WO2007114861A2 (en) | 2005-11-28 | 2006-11-28 | Il-21 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009517406A JP2009517406A (ja) | 2009-04-30 |
| JP2009517406A5 true JP2009517406A5 (enExample) | 2011-12-15 |
Family
ID=38564113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008542538A Pending JP2009517406A (ja) | 2005-11-28 | 2006-11-28 | Ｉｌ−２１受容体アンタゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7592427B2 (enExample) |
| EP (1) | EP1960433A2 (enExample) |
| JP (1) | JP2009517406A (enExample) |
| AU (1) | AU2006341398B9 (enExample) |
| CA (1) | CA2632218A1 (enExample) |
| IL (1) | IL190686A0 (enExample) |
| WO (1) | WO2007114861A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6307024B1 (en) | 1999-03-09 | 2001-10-23 | Zymogenetics, Inc. | Cytokine zalpha11 Ligand |
| JP5322653B2 (ja) * | 2005-11-28 | 2013-10-23 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−２１アンタゴニスト |
| JP5745274B2 (ja) | 2007-12-07 | 2015-07-08 | ザイモジェネティクス， インコーポレイテッド | 抗ヒトｉｌ−２１モノクローナル抗体 |
| JP5913103B2 (ja) | 2009-09-14 | 2016-04-27 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ | 酵母ベースの免疫療法組成物を含む組合せ物及び被験者のスクリーニング方法 |
| WO2013096732A2 (en) * | 2011-12-23 | 2013-06-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treating or preventing viral diseases by blocking interleukin-21 |
| US9823246B2 (en) | 2011-12-28 | 2017-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon |
| DE102014101565A1 (de) * | 2013-11-08 | 2015-05-13 | Sartorius Lab Instruments Gmbh & Co. Kg | Komparatorwaage mit abnehmbarem Klimamodul |
| AR099625A1 (es) * | 2014-03-21 | 2016-08-03 | Lilly Co Eli | Anticuerpos de il-21 |
| PT3128997T (pt) | 2014-04-08 | 2020-09-04 | Boston Pharmaceuticals Inc | Moléculas de ligação específicas para il-21 e suas utilizações |
| EP3215846B1 (en) | 2014-11-05 | 2020-03-11 | Nirmidas Biotech, Inc. | Metal composites for enhanced imaging |
| CA2978449A1 (en) | 2015-03-02 | 2016-09-09 | 180 Therapeutics Lp | Method of treating a localized fibrotic disorder using an il-33 antagonist |
| CA3071376A1 (en) | 2017-08-03 | 2019-02-07 | Amgen Inc. | Interleukin-21 muteins and methods of treatment |
| AU2019207895A1 (en) | 2018-01-12 | 2020-06-18 | Amgen Inc. | Anti-PD-1 antibodies and methods of treatment |
| US12012441B2 (en) | 2020-10-26 | 2024-06-18 | Neptune Biosciences Llc | Engineered human IL-21 cytokines and methods for using the same |
| CN114990206B (zh) * | 2022-06-02 | 2023-04-07 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | Common γ-chain受体作为药物靶点在制备治疗狼疮性肾炎药物中的应用 |
| EP4572772A1 (en) | 2022-08-17 | 2025-06-25 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3255699B2 (ja) * | 1992-04-23 | 2002-02-12 | 味の素株式会社 | ヒトＩＬ−２レセプターγ鎖分子 |
| TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| US6057128A (en) * | 1998-03-17 | 2000-05-02 | Genetics Institute, Inc. | MU-1, member of the cytokine receptor family |
| US6803451B2 (en) | 1998-09-23 | 2004-10-12 | Zymogenetics, Inc. | Cytokine receptor zalpha11 polypeptides |
| US6576744B1 (en) | 1998-09-23 | 2003-06-10 | Zymogenetics, Inc. | Cytokine receptor zalpha11 |
| AU2001253127A1 (en) | 2000-04-05 | 2001-10-23 | Zymogenetics Inc. | Soluble zalpha11 cytokine receptors |
| AU2003230834A1 (en) | 2002-04-09 | 2003-10-27 | Beth Israel Deaconess Medical Center, Inc. | Antagonists of il-21 and modulation of il-21-mediated t cell responses |
| US20040016010A1 (en) * | 2002-04-17 | 2004-01-22 | Marion Kasaian | IL-21 receptor knockout animal and methods of use thereof |
| KR101228124B1 (ko) * | 2002-06-14 | 2013-01-31 | 이뮤노메딕스, 인코오포레이티드 | 단클론 항체 ｐａｍ4 및 췌장암의 진단 및 치료를 위한이들의 용도 |
| KR20050037552A (ko) * | 2002-07-15 | 2005-04-22 | 와이어쓰 | Ｔ 헬퍼(ｔｈ) 세포 발생 및 기능을 조절하는 방법 및조성물 |
| JP4914209B2 (ja) * | 2003-03-14 | 2012-04-11 | ワイス | ヒトｉｌ−２１受容体に対する抗体および該抗体の使用 |
| MXPA05010035A (es) * | 2003-03-21 | 2005-11-17 | Wyeth Corp | Tratamiento de desordenes inmunologicos usando agonistas de interleucina-21/receptor de interleucina-21. |
| JP4471721B2 (ja) * | 2004-04-20 | 2010-06-02 | 独立行政法人産業技術総合研究所 | 抗インターロイキン２１受容体（ｉｌ−２１ｒ）抗体および本抗体を産生するハイブリドーマ |
| BRPI0510996A (pt) * | 2004-05-19 | 2007-12-04 | Wyeth Corp | métodos para melhorar um sintoma de um distúrbio atópico, e para tratar ou prevenir um distúrbio atópico em um paciente, métodos para modular a produção de igg e ige em uma célula, e nìveis relativos de ige e igg, composição farmacêutica, recipiente, métodos para avaliar um paciente tendo ou suspeito de ter um distúrbio atópico, e para avaliar um paciente quanto ao risco de um distúrbio atópico |
| TWI396686B (zh) * | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| US20070111941A1 (en) | 2004-06-09 | 2007-05-17 | Zymogenetics, Inc. | Cytokine receptor zalpha11 |
| US20060039902A1 (en) * | 2004-08-05 | 2006-02-23 | Young Deborah A | Antagonizing interleukin-21 receptor activity |
| ITRM20040586A1 (it) | 2004-11-29 | 2005-02-28 | Giuliani Spa | Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico. |
| JP5322653B2 (ja) | 2005-11-28 | 2013-10-23 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−２１アンタゴニスト |
-
2006
- 2006-11-28 AU AU2006341398A patent/AU2006341398B9/en not_active Ceased
- 2006-11-28 JP JP2008542538A patent/JP2009517406A/ja active Pending
- 2006-11-28 US US11/564,001 patent/US7592427B2/en active Active
- 2006-11-28 CA CA002632218A patent/CA2632218A1/en not_active Abandoned
- 2006-11-28 WO PCT/US2006/061285 patent/WO2007114861A2/en not_active Ceased
- 2006-11-28 EP EP06850199A patent/EP1960433A2/en not_active Withdrawn
-
2008
- 2008-04-08 IL IL190686A patent/IL190686A0/en unknown
-
2009
- 2009-08-14 US US12/541,544 patent/US20100008915A1/en not_active Abandoned
-
2010
- 2010-11-08 US US12/941,354 patent/US8790643B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009517406A5 (enExample) | ||
| JP2009517405A5 (enExample) | ||
| WO2015066379A3 (en) | Methods for enhancing immunosuppressive therapy by multiple administration of alpha beta tcr-binding polypeptide | |
| EP3004164A1 (en) | Novel antibodies | |
| PE20070183A1 (es) | Anticuerpos monoclonales anti-trkb | |
| NZ572807A (en) | Culture method for obtaining a clonal population of antigen-specific b cells | |
| RU2013152816A (ru) | АНТИТЕЛО ПРОТИВ ПРОТЕИНТИРОЗИНФОСФАТАЗЫ σ РЕЦЕПТОРНОГО ТИПА ЧЕЛОВЕКА | |
| Rouet et al. | Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies | |
| HK1201279A1 (en) | Antibody and methods for selective inhibition of t-cell responses | |
| RU2011145435A (ru) | БЛОКИРУЮЩИЕ АНТИТЕЛА ПРОТИВ Dkk-1 И ИХ ПРИМЕНЕНИЯ | |
| Tanaka et al. | Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics | |
| JP2013511996A5 (enExample) | ||
| WO2006116442A3 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| RU2012127378A (ru) | Средства для лечения заболевания | |
| Boshuizen et al. | A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2) | |
| US9938343B2 (en) | Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies | |
| MX2025004565A (es) | Anticuerpos anti-cd3 dependientes de ph y metodos relacionados con estos | |
| CN114573702A (zh) | 一种新型肿瘤衔接器治疗药物的开发和应用 | |
| CN113234159B (zh) | 抗lag3蛋白单克隆抗体及其细胞株、制备方法和应用 | |
| Lightwood et al. | Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells | |
| CN107383199B (zh) | 一种s-腺苷蛋氨酸合成酶的单克隆抗体及其应用 | |
| Tsuboi et al. | Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor | |
| RU2008152009A (ru) | Моноклональные антитела против аннексина а3 для обнаружения карциномы простаты | |
| WO2023036127A1 (zh) | 一种靶向IL-23p19的抗体或其抗原结合片段及其应用 | |
| RU2017145071A (ru) | Новый fab-фрагмент антитела к человеческому ngf |